Stoke Therapeutics, Inc.
US ˙ NasdaqGS ˙ US86150R1077

SecuritySTOK / Stoke Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership989,936 shares
Latest Disclosed Value $ 32,228,581
Dimensional Fund Advisors Lp reports 19.68% increase in ownership of STOK / Stoke Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 989,936 shares of Stoke Therapeutics, Inc. (US:STOK) valued at $32,232,316 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 827,139 shares of Stoke Therapeutics, Inc.. This represents a change in shares of 19.68% during the quarter. The current value of the position is $29,163,515 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F STOKE THERAPEUTICS COM 86150R107 989,936 162,797 19.68 32,229 22.76 0.0014
2026-02-12 2025-12-31 13F STOKE THERAPEUTICS COM 86150R107 827,139 148,832 21.94 26,254 64.64 0.0055
2025-11-12 2025-09-30 13F STOKE THERAPEUTICS COM 86150R107 678,307 4,423 0.66 15,946 108.47 0.0034
2025-08-12 2025-06-30 13F STOKE THERAPEUTICS COM 86150R107 673,884 9,149 1.38 7,650 72.94 0.0018
2025-05-13 2025-03-31 13F STOKE THERAPEUTICS COM 86150R107 664,735 125,835 23.35 4,423 -25.56 0.0011
2025-02-13 2024-12-31 13F STOKE THERAPEUTICS COM 86150R107 538,900 273,890 103.35 5,943 82.49 0.0014
2024-11-07 2024-09-30 13F STOKE THERAPEUTICS COM 86150R107 265,010 73,650 38.49 3,257 26.01 0.0008
2024-08-09 2024-06-30 13F STOKE THERAPEUTICS COM 86150R107 191,360 -28,405 -12.93 2,585 -12.88 0.0007
2024-05-10 2024-03-31 13F STOKE THERAPEUTICS COM 86150R107 219,765 4,471 2.08 2,967 162.01 0.0008
2024-02-07 2023-12-31 13F STOKE THERAPEUTICS COM 86150R107 215,294 -43,128 -16.69 1,133 11.31 0.0003
2023-11-09 2023-09-30 13F STOKE THERAPEUTICS COM 86150R107 258,422 -81,723 -24.03 1,018 -71.87 0.0003
2023-08-09 2023-06-30 13F STOKE THERAPEUTICS COM 86150R107 340,145 46,513 15.84 3,615 47.85 0.0012
2023-05-12 2023-03-31 13F STOKE THERAPEUTICS COM 86150R107 293,632 1,625 0.56 2,446 122,150.00 0.0008
2023-02-09 2022-12-31 13F STOKE THERAPEUTICS COM 86150R107 292,007 -46,989 -13.86 3 -99.95 0.0008
2022-11-10 2022-09-30 13F STOKE THERAPEUTICS COM 86150R107 338,996 73,975 27.91 4,353 24.34 0.0017
2022-08-12 2022-06-30 13F STOKE THERAPEUTICS COM 86150R107 265,021 113,361 74.75 3,501 9.61 0.0013
2022-05-13 2022-03-31 13F STOKE THERAPEUTICS COM 86150R107 151,660 79,518 110.22 3,194 84.52 0.0010
2022-02-09 2021-12-31 13F STOKE THERAPEUTICS COM 86150R107 72,142 27,423 61.32 1,731 52.11 0.0005
2021-11-12 2021-09-30 13F STOKE THERAPEUTICS COM 86150R107 44,719 -60,664 -57.57 1,138 -67.92 0.0004
2021-08-12 2021-06-30 13F STOKE THERAPEUTICS COM 86150R107 105,383 -3,440 -3.16 3,547 -15.91 0.0011
2021-05-14 2021-03-31 13F STOKE THERAPEUTICS COM 86150R107 108,823 69,010 173.34 4,218 71.12 0.0014
2021-03-08 2020-12-31 13F/A-2 STOKE THERAPEUTICS COM 86150R107 39,813 32,432 439.40 2,465 897.98 0.0009
2021-02-11 2020-12-31 13F STOKE THERAPEUTICS COM 86150R107 39,813 32,432 2,465 890.2270
2020-11-12 2020-09-30 13F STOKE THERAPEUTICS COM 86150R107 7,381 7,381 247 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.